Adjuvant for cancer immunotherapy

Details Adjuvant for cancer immunotherapy Adjuvant for cancer immunotherapy

C - Chemistry, Metallurgy

07

K

167/103.2

C07K 14/535 (2006.01) C07K 14/53 (2006.01) A61K 38/00 (2006.01)

Patent

CA 1336399

This invention relates to an adjuvant which comprises a colony stimulating factor as the active ingredient and which may be used with an immunoactivating agent in cancer immunotherapy. When thus used, the efficacy of the immunoactivating agent and its antitumour effect is remarkably increased when compared to the prior art.

589579

Affiliated with

Also associated with

Rating

Adjuvant for cancer immunotherapy does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Adjuvant for cancer immunotherapy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Adjuvant for cancer immunotherapy will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1330958